MYSOLINE cpr 250 mg 100 pce
7680178850145
CH-17885
N03AA03
01.07.1.
Reimbursement limitations:
MYSOLINE
Patients réfractaires à tous les autres traitements standard. Patients qui suivent déjà un traitement avec …
1 / 3
google
Details
- Product number
- 1788501
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- primidonum 250 mg, povidonum, gelatina, carmellosum calcicum, magnesii stearas, acidum stearicum pro compresso.
Articles (1)
Mysoline, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 43.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1955
Authorization holder
Curatis AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 17885
- Drug name
- Mysoline, Tabletten
- Galenic form
- TAB
- ATC Code
- N03AA03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/10/1952
- Authorization expiration date
- 31/12/9999
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MYSOLINE cpr 250 mg 100 pce
- Description (DE)
- MYSOLINE Tabl 250 mg 100 Stk
- Market launch
- 15/10/1952
- Narcotic (BTM)
- No